Marwa Mohammed Abdel Fattah Zaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marwa Mohammed Abdel Fattah Zaki has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Amira Kamal El-Hawary
2 shared publications- Sameh Shamaa
Mansoura University
2 shared publications Ahmed Aboelenen
Gastroenterology Surgical Center, Mansoura University, Egypt
1 shared publication- Ahmed Shehta
Gastrointestinal Surgery Center, Department of Surgery, Faculty of Medicine, Mansoura University, Egypt
1 shared publication - Amira Kamal El-Hawary
Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
1 shared publication Eman M. El-Salk
Gastroenterology Surgical Center, Mansoura University, Egypt
1 shared publication
Latest Publications
- 1 September 2018
- Published by Elsevier in Life Sciences
- Vol. 208, 64-71
Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects
- 1 September 2018
- Published by Elsevier in Life Sciences
- Vol. 208, 64-71
Nephroprotective effect of saxagliptin against gentamicin-induced nephrotoxicity, emphasis on anti-oxidant, anti-inflammatory and anti-apoptic effects
- Open Access
- 1 January 2018
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 7 (3) , 124-127
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Clinicopathological Review
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is aggressive hematopoietic malignancy derived from the precursors of plasmacytoid dendritic cells. The present study reported a case of a 35-year-old BPDCN patient, who presented with scalp lesions without extracutaneous involvement of the lymph nodes (LNs), peripheral or bone marrow. Histopathological examination of scalp lesion revealed monomorphous diffuse infiltrate of small to medium-sized cells with irregular nuclear contours, pleomorphic nuclei, finely dispersed chromatin, inconspicuous nucleoli and scant amount of cytoplasm. Immunohistochemical staining showed diffuse positivity for CD45, CD4, CD 56, CD45 and negative for CD3, CD5, CD7, CD8, CD19, CD20, CD30, CD33, CD34, CD79a, CD99, CD117, TDT, and myeloperoxidase. Patient started treatment with acute lymphoblastic lymphoma protocol (Hyper-CVAD). Reevaluation after the second course showed marked regression of scalp lesion. The patient continued Hyper-CVAD protocol and planned for allogeneic stem cell transplant. J Hematol. 2018;7(3):124-127 doi: https://doi.org/10.14740/jh428w
- 1 January 2018
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 7 (3) , 124-127
Open AccessBlastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Clinicopathological Review
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is aggressive hematopoietic malignancy derived from the precursors of plasmacytoid dendritic cells. The present study reported a case of a 35-year-old BPDCN patient, who presented with scalp lesions without extracutaneous involvement of the lymph nodes (LNs), peripheral or bone marrow. Histopathological examination of scalp lesion revealed monomorphous diffuse infiltrate of small to medium-sized cells with irregular nuclear contours, pleomorphic nuclei, finely dispersed chromatin, inconspicuous nucleoli and scant amount of cytoplasm. Immunohistochemical staining showed diffuse positivity for CD45, CD4, CD 56, CD45 and negative for CD3, CD5, CD7, CD8, CD19, CD20, CD30, CD33, CD34, CD79a, CD99, CD117, TDT, and myeloperoxidase. Patient started treatment with acute lymphoblastic lymphoma protocol (Hyper-CVAD). Reevaluation after the second course showed marked regression of scalp lesion. The patient continued Hyper-CVAD protocol and planned for allogeneic stem cell transplant. J Hematol. 2018;7(3):124-127 doi: https://doi.org/10.14740/jh428w
- Open Access
- 1 January 2018
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 7 (2) , 72-75
A Metastatic Signet Ring Cell Carcinoma Presented as Acquired Thrombotic Thrombocytopenic Purpura: A Case Report
A Metastatic Signet Ring Cell Carcinoma Presented as Acquired Thrombotic Thrombocytopenic Purpura: A Case Report
- 1 January 2018
- Published by Elmer Press, Inc. in Journal of Hematology
- Vol. 7 (2) , 72-75
Open AccessA Metastatic Signet Ring Cell Carcinoma Presented as Acquired Thrombotic Thrombocytopenic Purpura: A Case Report
A Metastatic Signet Ring Cell Carcinoma Presented as Acquired Thrombotic Thrombocytopenic Purpura: A Case Report
- 1 September 2017
- Published by Medknow in Current Medicine Research and Practice
- Vol. 7 (5) , 198-201
Bowel endometriosis: Report of three cases
- 1 September 2017
- Published by Medknow in Current Medicine Research and Practice
- Vol. 7 (5) , 198-201
Bowel endometriosis: Report of three cases
- Open Access
- 1 January 2014
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 5 (1) , 26-29
Right hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report
INTRODUCTION: Cases of primary neuroendocrine tumors in the liver combined with hepatocellular carcinoma are scarce. Such cases could present either as combined-type tumor or collision type. PRESENTATION OF CASE: A 51-year-old man presented with a mass in the right hemiliver. Serum level of alpha-fetoprotein was slightly elevated (2.3 ng/ml), with normal CA19-9 and CA125. The patient underwent right hepatectomy. The resected specimen showed a well-defined and heterogeneous gray-white to brown friable tumor, 20 cm in diameter. Microscopically, the tumor consisted predominantly of monotonous small- to medium-sized neoplastic cells arranged in trabeculea separated by sinusoidal spaces. Immunohistochemically, the tumor cells were strongly positive for synaptophysin and focally positive for chromogranin-A. Interestingly, the tumor cells showed patchy positive coarse granular staining of HerPar-1 involving about 1% of the tumor cells. Glypican-3 staining was negative. These immunohistochemical findings supported the diagnosis of combined high grade neuroendocrine carcinoma and hepatocellular carcinoma. DISCUSSION: Cases of primary neuroendocrine tumors in the liver combined 82 with hepatocellular carcinoma are scarce. The uniqueness of this case lies in the fact that the neuroendocrine carcinoma component comprised more than 99% of the tumor area, and the minor hepatocellular carcinoma component was detected only by the immunohistochemical staining for HepPar-1. CONCLUSION: To the best of our knowledge, this is the first case of combined neuroendocrine carcinoma and hepatocellular carcinoma in Egypt.
- 1 January 2014
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 5 (1) , 26-29
Open AccessRight hepatectomy for combined primary neuroendocrine and hepatocellular carcinoma. A case report
INTRODUCTION: Cases of primary neuroendocrine tumors in the liver combined with hepatocellular carcinoma are scarce. Such cases could present either as combined-type tumor or collision type. PRESENTATION OF CASE: A 51-year-old man presented with a mass in the right hemiliver. Serum level of alpha-fetoprotein was slightly elevated (2.3 ng/ml), with normal CA19-9 and CA125. The patient underwent right hepatectomy. The resected specimen showed a well-defined and heterogeneous gray-white to brown friable tumor, 20 cm in diameter. Microscopically, the tumor consisted predominantly of monotonous small- to medium-sized neoplastic cells arranged in trabeculea separated by sinusoidal spaces. Immunohistochemically, the tumor cells were strongly positive for synaptophysin and focally positive for chromogranin-A. Interestingly, the tumor cells showed patchy positive coarse granular staining of HerPar-1 involving about 1% of the tumor cells. Glypican-3 staining was negative. These immunohistochemical findings supported the diagnosis of combined high grade neuroendocrine carcinoma and hepatocellular carcinoma. DISCUSSION: Cases of primary neuroendocrine tumors in the liver combined 82 with hepatocellular carcinoma are scarce. The uniqueness of this case lies in the fact that the neuroendocrine carcinoma component comprised more than 99% of the tumor area, and the minor hepatocellular carcinoma component was detected only by the immunohistochemical staining for HepPar-1. CONCLUSION: To the best of our knowledge, this is the first case of combined neuroendocrine carcinoma and hepatocellular carcinoma in Egypt.